StockData
GeoVax Labs, Inc. logo

GeoVax Labs, Inc. (GOVX) stock

GOVXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$2.01−0.01 (-0.50%)

Close on Nov 17, 2026Market cap $14.81MP/E –Yield –

GeoVax Labs total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

GeoVax Labs's total debt was $0 at Dec 31, 2021. For fiscal 2021 it was $0, down 100.0% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2021Dec 31, 2021$0-100.0%
FY2020Dec 31, 2020$14.74K-45.9%
FY2019Dec 31, 2019$27.24K-31.2%
FY2018Dec 31, 2018$39.58K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2021Dec 31, 2021$0-100.0%
Q3 FY2021Sep 30, 2021$0-100.0%
Q2 FY2021Jun 30, 2021$0-100.0%
Q1 FY2021Mar 31, 2021$12.16K-50.9%
Q4 FY2020Dec 31, 2020$14.74K-45.9%
Q3 FY2020Sep 30, 2020$18.51K-36.6%
Q2 FY2020Jun 30, 2020$21.70K-32.8%
Q1 FY2020Mar 31, 2020$24.78K-30.0%
Q4 FY2019Dec 31, 2019$27.24K-31.2%
Q3 FY2019Sep 30, 2019$29.17K-31.7%
Q2 FY2019Jun 30, 2019$32.29K-29.5%
Q1 FY2019Mar 31, 2019$35.42K-27.7%
Q4 FY2018Dec 31, 2018$39.58K–
Q3 FY2018Sep 30, 2018$42.71K–
Q2 FY2018Jun 30, 2018$45.83K–
Q1 FY2018Mar 31, 2018$48.96K–

More GeoVax Labs figures

See a number that looks wrong?